Panbela Therapeutics experiences a surge in its stock value after positive | |
Panbela Therapeutics Inc. witnessed a dramatic surge in its stock price following upbeat news from the U.S. Food and Drug Administration regarding a potential treatment for childhood cancer. The FDA granted approval for US WorldMeds’ new drug application employing eflornithine as a therapy for high-risk neuroblastoma patients—a rare form of cancer originating from immature nerve cells, contributing to nearly 15% of pediatric cancer fatalities. ![]() | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target State: All States Target City : New York City Last Update : Mar 12, 2025 2:50 AM Number of Views: 10 | Item Owner : medhealthinsight Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |